ReviewFrontiers in neurology2025
Comprehensive autonomic nervous system evaluation in stroke patients: heart rate variability as a cornerstone for recovery prediction.
Review in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Autonomic nervous system (ANS) dysfunction significantly impacts stroke outcomes, yet standardized autonomic monitoring remains underutilized in clinical practice. Recent evidence highlights heart rate variability (HRV) as a robust prognostic marker, while complementary modalities like blood pressure variability (BPV) and pupillometry enhance risk stratification. Objective: To synthesize current evidence on multimodal ANS assessment in stroke patients, with HRV as the cornerstone biomarker, and provide practical recommendations for clinical implementation. Methods: We conducted a narrative review of peer-reviewed studies (2018-2024) from major databases, focusing on HRV and complementary ANS modalities in stroke patients. The analysis included 53 studies from diverse global regions, with a specific focus on technology-enabled investigations and prospective cohorts that emerged from 2022 to 2024. Results: Time-domain HRV metrics such as SDNN (standard deviation of all normal-to-normal RR intervals) and RMSSD (root mean square of successive differences) consistently predicted functional outcomes and cardiovascular complications post-stroke. Beat-to-beat blood pressure variability (BPV) within the first 24 h post-ischemic stroke outperforms HRV alone for short-term prognosis, with an AUC improvement of 10-15%. Nocturnal HRV combined with BPV and endothelial function enhanced prediction of recurrent cerebrovascular events. Automated pupillometry, with Neurological Pupil index (NPi < 3), predicts post-stroke delirium; integration with HRV metrics improves prognostic accuracy. Consumer-grade wearables demonstrated high agreement with ECG standards, enabling scalable remote monitoring. Conclusion: HRV-centered multimodal ANS assessment offers robust, non-invasive prognostic tools for stroke management. Integration with BPV, pupillometry, and wearable technology enhances risk stratification across acute and rehabilitation phases. Standardized protocols and technology adoption could transform stroke outcomes globally, particularly in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.